Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK NEVEUX-ROELANS from Sint-Niklaas, company number BE0437102982, closed financial year 2025 with a result of € 88,183 after tax. For that financial year APOTHEEK NEVEUX-ROELANS recorded a gross margin of € 172,241 and equity of € 138,119. Compared with financial year 2024, the result moved from € 76,212 to € 88,183. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 138,119
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 88,183
▲ 16% vs 2024
Profit after tax over the fiscal year.
€ 99,431
▲ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 88,183 paid out
100 % of the profit went to the shareholders, mostly to NEVEUX (100 % of the shares). That is where the money ends up.
People and assets in 2025
0.4
Average over the fiscal year, from the social balance sheet.
€ 23,200
▲ 21% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 80,545
▼ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 297,977
▲ 20% vs 2024
€ 25,114 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 62,465
▼ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,657
▲ 63% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 87,585 | € 158,859 | € 155,503 | € 172,241 | ▲ 11% |
| Profit after taxes | € 22,827 | € 86,036 | € 76,212 | € 88,183 | ▲ 16% |
| Equity | € 60,083 | € 138,119 | € 138,119 | € 138,119 | |
| Total debts | € 587,832 | € 525,739 | € 493,672 | € 564,810 | ▲ 14% |
| Cash | € 83,633 | € 108,700 | € 77,441 | € 99,431 | ▲ 28% |
| Land & buildings | € 179,911 | € 168,383 | € 155,729 | € 227,030 | ▲ 46% |
| Retained profit | € 41,491 | € 119,527 | € 119,527 | € 119,527 | |
| Dividend | € 0 | € 8,000 | € 76,212 | € 88,183 | ▲ 16% |
| Bank debt | € 284,999 | € 266,755 | € 248,243 | € 297,977 | ▲ 20% |
| Balance sheet total | € 647,915 | € 663,858 | € 631,791 | € 702,929 | ▲ 11% |
| Employees (FTE) | 0.2 | 0.4 | 0.4 | 0.4 |
By gross margin, APOTHEEK NEVEUX-ROELANS ranks 12th of 19 companies with main activity “Detailhandel in farmaceutische producten” in Sint-Niklaas that publish figures (fiscal year 2025).
Key figures of APOTHEEK NEVEUX-ROELANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about APOTHEEK NEVEUX-ROELANS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to APOTHEEK NEVEUX-ROELANS?
What happened at APOTHEEK NEVEUX-ROELANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 88,183 (▲ 16% vs 2024). filed late Source: NBB ↗
- Neveux BV became a director. NBB
- New establishment in Sint-Niklaas. KBO
- Start of the company according to the CBE. KBO
In short
From € 22,827 profit in 2022 to € 88,183 profit in 2025.
Paid € 21,733 in corporate taxes since 2022.
Best year ever: 2025, with € 88,183 profit.
Paid out € 172,394 in dividends to the owners in total.
Management
The stake of NEVEUX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK NEVEUX-ROELANSBehind APOTHEEK NEVEUX-ROELANS is Neveux BV. The shares are held by NEVEUX (99.9%).
Establishments
Establishment units
Physical locations of this company
Moerlandstraat 104
9100 Sint-Niklaas
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Sint-Niklaas
Same main activity (Detailhandel in farmaceutische producten), 19 active companies in Sint-Niklaas, largest first.
€ 643,461 gross margin · 2025
€ 564,241 gross margin · 2025
€ 524,180 gross margin · 2025
€ 456,234 gross margin · 2025
€ 349,467 gross margin · 2025
€ 333,438 gross margin · 2025
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
DSTNY-BACKBONE International Backbone, BE
Website info
Features
Security
Details
- Company number
- 0437.102.982
- VAT number
- BE 0437.102.982
- Registered office
- Moerlandstraat 104, 9100 Sint-Niklaas
- Names & denominations
- APOTHEEK NEVEUX-ROELANS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 March 1989
- Peppol
- Active · Active since 4 Jul 2025
- Contact
- aponr.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers